Portopulmonary Hypertension in Liver Transplantation: Diagnostic Challenges and Perioperative Management of the Right Ventricular Dysfunction
Bruno Pessoa Chacon; Marina Ayres Delgado, MD, PhD*; André Dos Santos Mendonça, MD; David Ribeiro Do Nascimento, MD
Portopulmonary Hypertension (PPH), a pulmonary vascular complication associated with portal hypertension, affects 2-5% of chronic liver disease patients. PPH’s pathogenesis involves pulmonary vasoconstriction, thrombosis, and endothelial and smooth muscle proliferation.